vs
La Rosa Holdings Corp.（LRHC）与自然阳光（NATR）财务数据对比。点击上方公司名可切换其他公司
自然阳光的季度营收约是La Rosa Holdings Corp.的6.1倍（$123.8M vs $20.2M）。自然阳光净利率更高（3.3% vs -27.4%，领先30.7%）。自然阳光同比增速更快（4.7% vs 3.2%）。过去两年La Rosa Holdings Corp.的营收复合增速更高（72.5% vs 5.6%）
拉罗萨控股旗下的万拉罗萨父子通心粉公司由西西里移民文森佐·拉罗萨于1914年创立，发展至今已成为美国规模领先的区域知名食品品牌，可生产四十余种意面产品，在当地市场拥有较高的认可度。
自然阳光产品公司（简称NSP）主营膳食补充剂与个人护理产品的生产制造，产品涵盖草本补充剂、维生素、矿物质制剂等品类。公司总部设于犹他州利希，生产工厂位于犹他州西班牙福克，是该领域知名的健康产品生产商。
LRHC vs NATR — 直观对比
营收规模更大
NATR
是对方的6.1倍
$20.2M
营收增速更快
NATR
高出1.6%
3.2%
净利率更高
NATR
高出30.7%
-27.4%
两年增速更快
LRHC
近两年复合增速
5.6%
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $20.2M | $123.8M |
| 净利润 | $-5.5M | $4.1M |
| 毛利率 | 8.4% | 72.5% |
| 营业利润率 | -24.7% | 4.3% |
| 净利率 | -27.4% | 3.3% |
| 营收同比 | 3.2% | 4.7% |
| 净利润同比 | -125.7% | 1379.4% |
| 每股收益（稀释后） | $-5.44 | $0.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LRHCNATR
| Q4 25 | — | $123.8M | ||
| Q3 25 | $20.2M | $128.3M | ||
| Q2 25 | $23.2M | $114.8M | ||
| Q1 25 | $17.5M | $113.2M | ||
| Q4 24 | $17.7M | $118.2M | ||
| Q3 24 | $19.6M | $114.6M | ||
| Q2 24 | $19.1M | $110.6M | ||
| Q1 24 | $13.1M | $111.0M |
净利润LRHCNATR
| Q4 25 | — | $4.1M | ||
| Q3 25 | $-5.5M | $5.3M | ||
| Q2 25 | $78.4M | $5.3M | ||
| Q1 25 | $-95.7M | $4.7M | ||
| Q4 24 | $-5.1M | $-321.0K | ||
| Q3 24 | $-2.5M | $4.3M | ||
| Q2 24 | $-2.3M | $1.3M | ||
| Q1 24 | $-4.6M | $2.3M |
毛利率LRHCNATR
| Q4 25 | — | 72.5% | ||
| Q3 25 | 8.4% | 73.3% | ||
| Q2 25 | 8.0% | 71.7% | ||
| Q1 25 | 8.8% | 72.1% | ||
| Q4 24 | 8.9% | 72.0% | ||
| Q3 24 | 8.3% | 71.3% | ||
| Q2 24 | 8.3% | 71.4% | ||
| Q1 24 | 8.9% | 71.2% |
营业利润率LRHCNATR
| Q4 25 | — | 4.3% | ||
| Q3 25 | -24.7% | 7.0% | ||
| Q2 25 | -10.6% | 3.7% | ||
| Q1 25 | -26.7% | 5.4% | ||
| Q4 24 | -17.1% | 3.8% | ||
| Q3 24 | -8.9% | 4.6% | ||
| Q2 24 | -9.7% | 5.1% | ||
| Q1 24 | -35.0% | 4.2% |
净利率LRHCNATR
| Q4 25 | — | 3.3% | ||
| Q3 25 | -27.4% | 4.2% | ||
| Q2 25 | 337.8% | 4.6% | ||
| Q1 25 | -546.5% | 4.2% | ||
| Q4 24 | -28.7% | -0.3% | ||
| Q3 24 | -12.5% | 3.8% | ||
| Q2 24 | -12.2% | 1.2% | ||
| Q1 24 | -35.1% | 2.1% |
每股收益（稀释后）LRHCNATR
| Q4 25 | — | $0.23 | ||
| Q3 25 | $-5.44 | $0.30 | ||
| Q2 25 | $15.25 | $0.28 | ||
| Q1 25 | $-5.86 | $0.25 | ||
| Q4 24 | $28.54 | $-0.02 | ||
| Q3 24 | $-16.49 | $0.23 | ||
| Q2 24 | $-12.49 | $0.07 | ||
| Q1 24 | $-0.35 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.0M | $93.9M |
| 总债务越低越好 | $642.8K | — |
| 股东权益账面价值 | $1.6M | $161.6M |
| 总资产 | $21.7M | $261.1M |
| 负债/权益比越低杠杆越低 | 0.41× | — |
8季度趋势，按日历期对齐
现金及短期投资LRHCNATR
| Q4 25 | — | $93.9M | ||
| Q3 25 | $4.0M | $95.6M | ||
| Q2 25 | $5.1M | $81.3M | ||
| Q1 25 | $2.9M | $86.5M | ||
| Q4 24 | $1.4M | $84.7M | ||
| Q3 24 | $1.8M | $78.7M | ||
| Q2 24 | $1.6M | $68.7M | ||
| Q1 24 | $1.1M | $77.8M |
总债务LRHCNATR
| Q4 25 | — | — | ||
| Q3 25 | $642.8K | — | ||
| Q2 25 | $644.3K | — | ||
| Q1 25 | $645.9K | — | ||
| Q4 24 | $647.6K | — | ||
| Q3 24 | $649.2K | — | ||
| Q2 24 | $650.8K | — | ||
| Q1 24 | $652.4K | $2.1M |
股东权益LRHCNATR
| Q4 25 | — | $161.6M | ||
| Q3 25 | $1.6M | $166.7M | ||
| Q2 25 | $3.4M | $163.7M | ||
| Q1 25 | $-87.5M | $167.1M | ||
| Q4 24 | $2.6M | $161.0M | ||
| Q3 24 | $5.0M | $162.6M | ||
| Q2 24 | $4.7M | $156.4M | ||
| Q1 24 | $5.6M | $159.7M |
总资产LRHCNATR
| Q4 25 | — | $261.1M | ||
| Q3 25 | $21.7M | $264.8M | ||
| Q2 25 | $22.9M | $254.9M | ||
| Q1 25 | $21.0M | $252.7M | ||
| Q4 24 | $19.4M | $240.9M | ||
| Q3 24 | $19.7M | $245.3M | ||
| Q2 24 | $18.7M | $235.8M | ||
| Q1 24 | $16.3M | $247.3M |
负债/权益比LRHCNATR
| Q4 25 | — | — | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.12× | 0.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.3M | $9.9M |
| 自由现金流经营现金流 - 资本支出 | — | $7.6M |
| 自由现金流率自由现金流/营收 | — | 6.1% |
| 资本支出强度资本支出/营收 | — | 1.9% |
| 现金转化率经营现金流/净利润 | — | 2.41× |
| 过去12个月自由现金流最近4个季度 | — | $28.8M |
8季度趋势，按日历期对齐
经营现金流LRHCNATR
| Q4 25 | — | $9.9M | ||
| Q3 25 | $-1.3M | $18.5M | ||
| Q2 25 | $-1.4M | $4.3M | ||
| Q1 25 | $-3.5M | $2.6M | ||
| Q4 24 | $-1.1M | $12.2M | ||
| Q3 24 | $-591.6K | $9.6M | ||
| Q2 24 | $-803.1K | $1.3M | ||
| Q1 24 | $-538.3K | $2.2M |
自由现金流LRHCNATR
| Q4 25 | — | $7.6M | ||
| Q3 25 | — | $16.8M | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | — | $10.0M | ||
| Q3 24 | — | $7.9M | ||
| Q2 24 | — | $-2.0M | ||
| Q1 24 | — | $-1.5M |
自由现金流率LRHCNATR
| Q4 25 | — | 6.1% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | — | 6.9% | ||
| Q2 24 | — | -1.9% | ||
| Q1 24 | — | -1.4% |
资本支出强度LRHCNATR
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 3.3% |
现金转化率LRHCNATR
| Q4 25 | — | 2.41× | ||
| Q3 25 | — | 3.46× | ||
| Q2 25 | -0.02× | 0.81× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.21× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | — | 0.94× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LRHC
| Real Estate Residential Brokerage Services | $16.8M | 83% |
| Transferred Over Time | $3.5M | 17% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
